Lipoedema and Bariatric and Metabolic Surgery: A Systematic Review

IF 2.4 Q3 ENDOCRINOLOGY & METABOLISM
Clinical Obesity Pub Date : 2025-12-23 DOI:10.1111/cob.70062
Qamil Pajaziti, Georgios Geropoulos, Emma MacVicar, Nicola Colucci, James Lucocq, Peter J. Lamb, Andrew G. Robertson
{"title":"Lipoedema and Bariatric and Metabolic Surgery: A Systematic Review","authors":"Qamil Pajaziti,&nbsp;Georgios Geropoulos,&nbsp;Emma MacVicar,&nbsp;Nicola Colucci,&nbsp;James Lucocq,&nbsp;Peter J. Lamb,&nbsp;Andrew G. Robertson","doi":"10.1111/cob.70062","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Lipoedema is a chronic, progressive condition characterised by disproportionate fat accumulation in the lower extremities, often misdiagnosed due to symptom overlap with obesity. Weight management is a key component of lipoedema treatment, yet the role of bariatric surgery remains unclear. This systematic review evaluates the impact of bariatric and metabolic surgery (BMS) on lipoedema symptoms, weight loss outcomes, and the need for further interventions. A systematic search of PubMed, Scopus and the Cochrane Library was conducted up to January 2025 following PRISMA guidelines. Studies reporting on patients with lipoedema (or equivalent diagnoses) who underwent BMS were included. Quality was assessed using the Joanna Briggs Institute (JBI) checklist for case reports and the National Heart, Lung and Blood Institute (NHLBI) tool for case series. Seven studies met the inclusion criteria (five case reports, two cohort studies), comprising 51 patients. All underwent BMS, primarily sleeve gastrectomy or Roux-en-Y gastric bypass. One study (<i>n</i> = 31) reported a significant reduction in thigh volume and weight loss comparable to controls. The remaining studies found persistent or worsened lower body disproportionality and no improvement in pain. Postoperative lipoedema diagnoses were common, raising concerns over diagnostic accuracy. Overall weight loss averaged 33.9% total weight loss. Bariatric and metabolic surgery achieves meaningful weight reduction in patients with lipoedema and obesity but does not consistently improve core lipoedema symptoms. Its role remains adjunctive rather than primary. Preoperative identification and documentation of lipoedema features are recommended, with a postoperative plan for adjunct conservative therapies and selective consideration of lymph-sparing liposuction where symptoms persist. Larger prospective studies using standardised definitions and outcome measures are needed to clarify its therapeutic value in this population.</p>\n </div>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"16 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Obesity","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cob.70062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Lipoedema is a chronic, progressive condition characterised by disproportionate fat accumulation in the lower extremities, often misdiagnosed due to symptom overlap with obesity. Weight management is a key component of lipoedema treatment, yet the role of bariatric surgery remains unclear. This systematic review evaluates the impact of bariatric and metabolic surgery (BMS) on lipoedema symptoms, weight loss outcomes, and the need for further interventions. A systematic search of PubMed, Scopus and the Cochrane Library was conducted up to January 2025 following PRISMA guidelines. Studies reporting on patients with lipoedema (or equivalent diagnoses) who underwent BMS were included. Quality was assessed using the Joanna Briggs Institute (JBI) checklist for case reports and the National Heart, Lung and Blood Institute (NHLBI) tool for case series. Seven studies met the inclusion criteria (five case reports, two cohort studies), comprising 51 patients. All underwent BMS, primarily sleeve gastrectomy or Roux-en-Y gastric bypass. One study (n = 31) reported a significant reduction in thigh volume and weight loss comparable to controls. The remaining studies found persistent or worsened lower body disproportionality and no improvement in pain. Postoperative lipoedema diagnoses were common, raising concerns over diagnostic accuracy. Overall weight loss averaged 33.9% total weight loss. Bariatric and metabolic surgery achieves meaningful weight reduction in patients with lipoedema and obesity but does not consistently improve core lipoedema symptoms. Its role remains adjunctive rather than primary. Preoperative identification and documentation of lipoedema features are recommended, with a postoperative plan for adjunct conservative therapies and selective consideration of lymph-sparing liposuction where symptoms persist. Larger prospective studies using standardised definitions and outcome measures are needed to clarify its therapeutic value in this population.

脂肪水肿、肥胖和代谢手术:系统综述。
脂肪水肿是一种慢性进行性疾病,其特征是下肢脂肪堆积不成比例,常因症状与肥胖重叠而误诊。体重管理是脂肪水肿治疗的关键组成部分,但减肥手术的作用尚不清楚。本系统综述评估了减肥和代谢手术(BMS)对脂水肿症状、体重减轻结果和进一步干预的必要性的影响。按照PRISMA的指导方针,对PubMed、Scopus和Cochrane图书馆进行了到2025年1月的系统检索。研究报告了脂水肿(或同等诊断)患者接受BMS。使用乔安娜布里格斯研究所(JBI)病例报告检查表和国家心肺血液研究所(NHLBI)病例系列工具评估质量。7项研究符合纳入标准(5例病例报告,2项队列研究),包括51例患者。所有人都接受了BMS,主要是袖胃切除术或Roux-en-Y胃旁路术。一项研究(n = 31)报告了与对照组相比,大腿体积和体重的显著减少。其余的研究发现持续或恶化的下半身不均衡和疼痛没有改善。术后脂肪水肿诊断是常见的,引起了对诊断准确性的关注。总体减重平均为33.9%。减肥和代谢手术在脂肪水肿和肥胖患者中实现了有意义的体重减轻,但并不能持续改善核心脂肪水肿症状。它的作用仍然是辅助的,而不是主要的。建议术前识别和记录脂肪水肿特征,术后计划辅助保守治疗,如果症状持续存在,可选择性考虑保留淋巴的吸脂术。需要使用标准化定义和结果测量的更大的前瞻性研究来阐明其在该人群中的治疗价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Obesity
Clinical Obesity ENDOCRINOLOGY & METABOLISM-
CiteScore
5.90
自引率
3.00%
发文量
59
期刊介绍: Clinical Obesity is an international peer-reviewed journal publishing high quality translational and clinical research papers and reviews focussing on obesity and its co-morbidities. Key areas of interest are: • Patient assessment, classification, diagnosis and prognosis • Drug treatments, clinical trials and supporting research • Bariatric surgery and follow-up issues • Surgical approaches to remove body fat • Pharmacological, dietary and behavioural approaches for weight loss • Clinical physiology • Clinically relevant epidemiology • Psychological aspects of obesity • Co-morbidities • Nursing and care of patients with obesity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书